...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AACR 2018
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Thanks for that perspective tada. I guess I find it hard to live in the dark.

I would think that it must be extremely busy at Zenith on both the science side and the business side. 

For me I'm hoping Pfizer is keeping a close eye on the zen3694 findngs.

Bear, I sure hope for new positive information at the next conference.

GLTA

Toinv

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply